Endo to buy Par Pharmaceutical for $8.05 billion
Endo International will buy Par Pharmaceutical Holdings in a $8.05 billion deal that will strengthen Endo`s generic drugs business, the companies said Monday.
May 18, 2015, 20:48 PM IST
Endo International